Xanthine oxidase mediates stress-induced Alzheimer's Disease progression in triple transgenic mice

Abstract

Alzheimer’s disease (AD) is a progressive disorder associated with oxidative stress and neuroinflammation promoting the deposition of β-amyloid (Aβ) plaques and neurofibrillary tau tangles. Xanthine oxidoreductase (XOR) is a molybdoenzyme responsible for the metabolism of hypoxanthine and xanthine to uric acid. Under inflammatory conditions, high plasma uric acid levels upregulate XOR leading to increased free radical production and promoting cerebrovascular dysfunction. Chronic stress induces cerebrovascular dysfunction and cognitive decline in C57BL/6 mice mediated by XOR, suggesting a link between chronic stress and dementia. However, there is no published data that link XOR and stress to AD pathology and progression. Thus, we tested the hypothesis that chronic stress accelerates AD pathology via the XOR pathway.At 4 months of age, male and female WT (B6129) and triple transgenic (3xTg) AD mice underwent the Unpredictable Chronic Mild Stress (UCMS) model paradigm for 8 weeks. Mice were euthanized at two different time points at 6 and 9 months of age for both control and UCMS groups, and the tissues were harvested. Brain tissue lysates were homogenized, and the total tau and XOR protein was quantified using Western blot and normalized to β-actin. Aβ (1-40) levels in mouse brain homogenates using Aβ ELISA kit. Immunohistochemical staining was performed to study the colocalization of XO and CD-31 in WT and 3xTg coronal sections and analyzed using Fiji ImageJ.UCMS accelerated Aβ(1-40) expression levels (p<0.05) at both 6 and 9 months of age in the 3xTg mice. Tau levels were significantly increased at 6 months of age (p<0.05), but showed no significant differences in protein expression at 9 months of age. XOR levels were significantly upregulated (p<0.05) in the UCMS group at 6 months of age. At 9 months of age, no significant differences were seen in XOR expression across groups indicating that mice taken off from the UCMS protocol had normal levels of XOR due to reduced oxidative stress buildup in the brain. At 6 months of age, a significant decrease in microvessel density (p<0.05) was seen in 3xTg-UCMS mice vs 3xTg controls, with no significant differences seen at 9 months of age, indicating the role of chronic stress on the decline in cerebrovascular functions. Thus, the study establishes the premise that chronic stress mediated by XOR accelerates AD pathology in our early-onset AD model. NIH, NINDS BINP R01 NS117754, Psychosocial Stress-Induced Vascular Contributions to Cognitive Impairment and Alzheimer's Disease: The Role of Xanthine Oxidase This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.